Ibuprofen, aspirin, naproxen may be equally effective at reducing risk of Alzheimer's disease

May 28, 2008

Different types of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, naproxen, and aspirin, appear to be equally effective in lowering the risk of Alzheimer’s disease, according to the largest study of its kind published in the May 28, 2008, online issue of Neurology, the medical journal of the American Academy of Neurology. Experts have debated whether a certain group of NSAIDs that includes ibuprofen may be more beneficial than another group that includes naproxen and aspirin.

Using information from six different studies, researchers examined data on NSAID use in 13,499 people without dementia. Over the course of these six studies, 820 participants developed Alzheimer’s disease.

Researchers found that people who used NSAIDs had 23 percent lower risk of developing Alzheimer’s disease compared to those who never used NSAIDs. The risk reduction did not appear to depend upon the type of NSAID taken.

“This is an interesting finding because it seems to challenge a current theory that the NSAID group which includes ibuprofen may work better in reducing a person’s risk of Alzheimer’s,” said study author Peter P. Zandi, PhD, with Johns Hopkins Bloomberg School of Public Health in Baltimore, MD. “The NSAID group that includes ibuprofen was thought to target a certain type of plaque in the brain found in Alzheimer’s patients. But our results suggest there may be other reasons why these drugs may reduce the risk of Alzheimer’s.”

The study’s lead author Chris Szekely, PhD, with Cedars Sinai Medical Center in Los Angeles, says the discrepancy between studies such as this one and the negative clinical trials of NSAIDs in treatment or prevention of Alzheimer’s need to be further explored.

Source: American Academy of Neurology

Explore further: Global Ebola toll rises to 5,689: WHO

add to favorites email to friend print save as pdf

Related Stories

Geologists cite hair as 'human provenance tool'

7 minutes ago

Scott Samson, professor of Earth sciences and a faculty fellow of the Forensic and National Security Sciences Institute (FNSSI), is leading a multiyear study of strontium (Sr), a metallic element found in ...

NSA Director: China can damage US power grid

11 minutes ago

China and "one or two" other countries are capable of mounting cyberattacks to shut down the electric grid in parts of the United States. That's according to Admiral Michael Rogers, the director of the National Security Agency ...

Protecting personal data in the cloud

27 minutes ago

IBM today announced it has patented the design for a data privacy engine that can more efficiently and affordably help businesses protect personal data as it is transferred between countries, including across private clouds.

Recommended for you

Global Ebola toll rises to 5,689: WHO

4 hours ago

The World Health Organization said Thursday that the global death toll from the Ebola virus had increased to 5,689 out of a total of 15,935 cases of infection, mainly in western Africa.

Ebola vaccine promising in first human trials

15 hours ago

Researchers say they're a step closer to developing an Ebola vaccine, with a Phase 1 trial showing promising results, but it will be months at the earliest before it can be used in the field.

At one month, US Ebola monitors finding no cases

17 hours ago

The U.S. program that requires weeks of monitoring for travelers from African countries with Ebola reaches the one-month mark Thursday. And so far, no cases of the disease have turned up.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.